Pharmateca
ISSN 2073-4034 (Print)
ISSN 2414-9128 (Online)
Menu
Archives
Home
About the Journal
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Retracted articles
Archives
Contact
Subscriptions
Editorial Board
All Journals
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Subscription
Login to verify subscription
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
Categories
Keywords
COVID-19
Helicobacter pylori
antibacterial therapy
arterial hypertension
breast cancer
bronchial asthma
chemotherapy
children
chronic obstructive pulmonary disease
diabetes mellitus
gastroesophageal reflux disease
insulin resistance
metabolic syndrome
non-steroidal anti-inflammatory drugs
osteoporosis
pregnancy
probiotics
proton pump inhibitors
stroke
type 2 diabetes mellitus
vitamin D
×
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Subscription
Login to verify subscription
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
Categories
Keywords
COVID-19
Helicobacter pylori
antibacterial therapy
arterial hypertension
breast cancer
bronchial asthma
chemotherapy
children
chronic obstructive pulmonary disease
diabetes mellitus
gastroesophageal reflux disease
insulin resistance
metabolic syndrome
non-steroidal anti-inflammatory drugs
osteoporosis
pregnancy
probiotics
proton pump inhibitors
stroke
type 2 diabetes mellitus
vitamin D
Home
>
Search
>
Author Details
Author Details
Antsiferov, M
Issue
Section
Title
File
No 3 (2009)
Articles
Vildagliptin - a new dipeptidylpeptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
No 3 (2009)
Articles
Prospects of the first human glucagon-like peptide 1 analog liraglutid use in the treatment of patients with type 2 diabetes mellitus
No 3 (2009)
Articles
Experience of incritinomimetic exenatide (Byetta) use in the treatment of patients with type 2 diabetes mellitus with obesity
No 3 (2009)
Articles
Possibilities of insulin glargine (Lantus ®) use for treatment of type 2 diabetes mellitus in the outpatient endocrinology services: an analysis of the register LAUREL
No 3 (2009)
Articles
Effect of alpha-lipoic acid (Tiogamma) on the quality of life of patients with diabetic peripheral polyneuropathy
No 17 (2009)
Articles
ROSIGLITAZON: BEZOPASNOST', EFFEKTIVNOST' I VLIYaNIE NA KARDIOVASKULYaRNYE ISKhODY U PATsIENTOV S SAKhARNYM DIABETOM TIPA 2
No 17 (2009)
Articles
DIABETIChESKAYa PERIFERIChESKAYa POLINEVROPATIYa: SOVREMENNYE PREDSTAVLENIYa O PATOGENEZE I PODKhODY K TERAPII
No 17 (2009)
Articles
INNOVATsIONNYY KOMBINIROVANNYY PREPARAT GALVUS MET (VILDAGLIPTIN + METFORMIN) V LEChENII SAKhARNOGO DIABETA TIPA 2
No 17 (2009)
Articles
GLIKEMIChESKIY KONTROL' U PATsIENTOV S SAKhARNYM DIABETOM TIPA 2 VO VREMYa INITsIATsII INSULINOTERAPII V REAL'NOY KLINIChESKOY PRAKTIKE ROSSIYSKOY FEDERATsII: REZUL'ATY ISSLEDOVANIYa CREDIT
No 3 (2010)
Articles
Use of long-acting insulin analogues in type 2 diabetes mellitus treatment (according to the data of international and Russian registries)
No 3 (2010)
Articles
New possibilities for diabetic peripheral neuropathy treatment
No 11 (2010)
Articles
Role of the long-acting somastatin analogue Sandostatin Lar in the treatment of acromegaly
No 16 (2010)
Articles
POTENTIALS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN TYPE 2 DIABETES MELLITUS: INITIATION AND CONTINUATION OF THERAPY
No 16 (2010)
Articles
CONTINUOUS SUBCUTANEOUS INSULIN INFUSION: EFFECTIVE METHOD FOR CONTROL OF TYPE 1 DIABETES MELLITUS
No 16 (2010)
Articles
ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR
No 3 (2011)
Articles
TYPE 2 DIABETES MELLITUS: POTENTIALS FOR ACHIEVEMENT OF OPTIMAL CONTROL WITHOUT SIDE EFFECTS
No 3 (2011)
Articles
INITIATION OF THERAPY WITH INSULIN PUMP IN PATIENTS WITH TYPE 1 DIABETES
No 3 (2011)
Articles
CLINICAL ASPECTS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: BENEFITS FOR DIFFERENT GROUPS OF PATIENTS
No 3 (2011)
Articles
CENTRAL DIABETES INSIPIDUS: MODERN CONCEPTS AND THERAPEUTIC APPROACHES
No 3 (2012)
Articles
GLUCAGON-LIKE PEPTIDE-1: FROM PHYSIOLOGY TO EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
No 3 (2012)
Articles
TYPE 2 DIABETES MELLITUS AND CONCOMITANT DISEASES: ADVANTAGES OF USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR SAXAGLIPTIN (ONGLYZA ®)
No 3 (2012)
Articles
APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS
No 3 (2012)
Articles
HOW TO EFFECTIVELY MANAGE TWO MAJOR DEFECTS IN TYPE 2 DIABETES MELLITUS?
No 7 (2012)
Articles
DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
No 7 (2012)
Articles
DPP-4 INHIBITORS: TODAY AND TOMORROW. WHAT WE EXPECT FROM INCRETIN-STIMULATING THERAPY?
This website uses cookies
You consent to our cookies if you continue to use our website.
About Cookies
TOP